Neeraj Bhatia

Neeraj Bhatia

Active Director Director DIN 08138472
DIN 08138472 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Neeraj Bhatia

Data last updated:

Neeraj Bhatia is a Director at Riemann Labs Private Limited (since 2018). The company operates in Pharma. Riemann Labs Private Limited reported revenue of ₹9.75 Cr (FY 2025).

DIN 08138472
Primary Designation Director
Industry Pharma
First Appointment 26 May 2018
Oldest Company Age 27 yrs
Largest company Riemann Labs Private Limited · ₹9.75 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Riemann Labs Private Limited U24232MP1999PTC013404
Director26 May 20181999₹9.75 Cr (FY 2025)Active

Board colleagues of Neeraj Bhatia

Directorship timeline

Open interactive timeline →
Riemann Labs Private Limited
Premium access

Shareholding and investment profile for Neeraj Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Bhatia

Neeraj Bhatia currently holds 1 directorship: Riemann Labs Private Limited (Director, since 26 May 2018, revenue ₹9.75 Cr (FY 2025)).

Neeraj Bhatia was first appointed on 26 May 2018 as Director at Riemann Labs Private Limited.

The current boards of Neeraj Bhatia's companies include Chandan Bhatia (Riemann Labs Private Limited), Navin Bhatia (Riemann Labs Private Limited), Rajesh Bhatia (Riemann Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available